Biomark Diagnostics Market Cap

Biomark Diagnostics has a market cap or net worth of $16.92 million as of May 5, 2025. Its market cap has increased by 0.89% in one year.

Market Cap

16.92M

Enterprise Value

17.99M

Revenue

107.75K

Ranking

n/a

PE Ratio

n/a

Stock Price

$0.17

Market Cap Chart

Since November 27, 2014, Biomark Diagnostics's market cap has decreased from 35.57M to 16.92M, a decrease of -52.43%. That is a compound annual growth rate of -6.87%.

Market Cap History

Date	Market Cap	% Change
May 2, 2025	16.92M	64.62%
Dec 30, 2024	10.28M	-24.05%
Dec 29, 2023	13.53M	27.76%
Dec 30, 2022	10.59M	-28.16%
Dec 30, 2021	14.74M	116.26%
Dec 30, 2020	6.82M	-49.96%
Dec 30, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro
Dec 30, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Endo Inc.	1.62B
Nika Pharmaceuticals	1.02B
Veradigm	746.57M
Tian'an Technology Group	546.22M
Glass House Brands	529.49M
Elite Pharmaceuticals	452.95M
Northwest Biotherapeutics	429.16M
CytoDyn	401.57M

Market Cap Rankings